Cocrystal Pharma, Inc. (COCP)
NASDAQ: COCP · Real-Time Price · USD
0.9583
-0.0025 (-0.26%)
At close: Feb 4, 2026, 4:00 PM EST
0.9600
+0.0017 (0.18%)
After-hours: Feb 4, 2026, 4:00 PM EST

Cocrystal Pharma Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Feb '26 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
132118166393
Market Cap Growth
-34.28%17.29%10.34%-74.94%-32.06%435.38%
Enterprise Value
79-12-26262
Last Close Price
0.962.021.721.957.8016.32
PS Ratio
-----46.30
PB Ratio
1.632.160.660.400.821.78
P/TBV Ratio
1.742.160.660.401.082.79
EV/Sales Ratio
-----30.84
Debt / Equity Ratio
0.210.190.070.010.010.01
Asset Turnover
-----0.05
Quick Ratio
5.424.568.3531.1438.0024.72
Current Ratio
5.784.778.9233.0438.4025.05
Return on Equity (ROE)
-94.94%-97.50%-54.54%-66.32%-21.81%-24.67%
Return on Assets (ROA)
-45.77%-49.98%-36.68%-18.86%-13.30%-14.48%
Return on Capital Employed (ROCE)
-109.40%-162.10%-75.60%-45.80%-18.30%-18.10%
Earnings Yield
-72.33%-85.17%-102.64%-244.58%-22.39%-10.35%
FCF Yield
-72.01%-80.25%-84.38%-135.46%-20.16%-10.80%
Buyback Yield / Dilution
-1.91%-5.42%-18.52%-10.58%-60.04%-73.32%
Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q